iBET

NEW OPEN CALL: TRANSVAC - European Vaccine Research and Development Infrastructure

13.03.2019

Open Call for Vaccine Development Services

TRANSVAC is an infrastructure project - funded by the European Commission in the context of Horizon 2020 - that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal to build an efficient and sustainable collaboration of experts and facilities to catalyse vaccine research in Europe.


TRANSVAC offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular. Except for the few cases indicated on the website, services are offered free of charge! Academic and non-academic research groups, SMEs and industries can apply but only to service infrastructures outside their own country.


The call for application was launched on 15 October 2017 and will remain open for the duration of the project (until April 2022) or until all services have been exhausted. Applications can be submitted at any time as soon as the application form for the next cut-off date is online and will be processed at pre-defined cut-off dates occurring every four months. The next cut-off date is on 15 April 2019.

For more information about the services offered by iBET within TRANSVAC2 (mammalian and insect cell expression platform screening, and preclinical GLP production and purification of candidate vaccines), please visit: www.transvac.org.

If you have any specific questions, you can contact the project management team at: transvacinfo@euvaccine.eu